Literature DB >> 20309674

Basic science and clinical application of stem cells in veterinary medicine.

I Ribitsch1, J Burk, U Delling, C Geißler, C Gittel, H Jülke, W Brehm.   

Abstract

Stem cells play an important role in veterinary medicine in different ways. Currently several stem cell therapies for animal patients are being developed and some, like the treatment of equine tendinopathies with mesenchymal stem cells (MSCs), have already successfully entered the market. Moreover, animal models are widely used to study the properties and potential of stem cells for possible future applications in human medicine. Therefore, in the young and emerging field of stem cell research, human and veterinary medicine are intrinsically tied to one another. Many of the pioneering innovations in the field of stem cell research are achieved by cooperating teams of human and veterinary medical scientists.Embryonic stem (ES) cell research, for instance, is mainly performed in animals. Key feature of ES cells is their potential to contribute to any tissue type of the body (Reed and Johnson, J Cell Physiol 215:329-336, 2008). ES cells are capable of self-renewal and thus have the inherent potential for exceptionally prolonged culture (up to 1-2 years). So far, ES cells have been recovered and maintained from non-human primate, mouse (Fortier, Vet Surg 34:415-423, 2005) and horse blastocysts (Guest and Allen, Stem Cells Dev 16:789-796, 2007). In addition, bovine ES cells have been grown in primary culture and there are several reports of ES cells derived from mink, rat, rabbit, chicken and pigs (Fortier, Vet Surg 34:415-423, 2005). However, clinical applications of ES cells are not possible yet, due to their in vivo teratogenic degeneration. The potential to form a teratoma consisting of tissues from all three germ lines even serves as a definitive in vivo test for ES cells.Stem cells obtained from any postnatal organism are defined as adult stem cells. Adult haematopoietic and MSCs, which can easily be recovered from extra embryonic or adult tissues, possess a more limited plasticity than their embryonic counterparts (Reed and Johnson, J Cell Physiol 215:329-336, 2008). It is believed that these stem cells serve as cell source to maintain tissue and organ mass during normal cell turnover in adult individuals. Therefore, the focus of attention in veterinary science is currently drawn to adult stem cells and their potential in regenerative medicine. Also experience gained from the treatment of animal patients provides valuable information for human medicine and serves as precursor to future stem cell use in human medicine.Compared to human medicine, haematopoietic stem cells only play a minor role in veterinary medicine because medical conditions requiring myeloablative chemotherapy followed by haematopoietic stem cell induced recovery of the immune system are relatively rare and usually not being treated for monetary as well as animal welfare reasons.In contrast, regenerative medicine utilising MSCs for the treatment of acute injuries as well as chronic disorders is gradually turning into clinical routine. Therefore, MSCs from either extra embryonic or adult tissues are in the focus of attention in veterinary medicine and research. Hence the purpose of this chapter is to offer an overview on basic science and clinical application of MSCs in veterinary medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20309674     DOI: 10.1007/10_2010_66

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  15 in total

1.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

Review 2.  Immunomodulation by mesenchymal stem cells in veterinary species.

Authors:  Danielle D Carrade; Dori L Borjesson
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

3.  Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells.

Authors:  Oksana Raabe; Katja Shell; Antonia Würtz; Christine Maria Reich; Sabine Wenisch; Stefan Arnhold
Journal:  Vet Res Commun       Date:  2011-05-26       Impact factor: 2.459

4.  Intra-articular transplantation of porcine adipose-derived stem cells for the treatment of canine osteoarthritis: A pilot study.

Authors:  Shen-Yang Tsai; Yun-Ching Huang; Ling-Ling Chueh; Lih-Seng Yeh; Ching-Shwun Lin
Journal:  World J Transplant       Date:  2014-09-24

5.  Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii.

Authors:  Aiping Qin; De-Hua Lai; Qifa Liu; Weijun Huang; Ya-Ping Wu; Xiaoyong Chen; Sunxing Yan; Huimin Xia; Geoff Hide; Zhao-Rong Lun; Francisco J Ayala; Andy Peng Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-25       Impact factor: 11.205

Review 6.  Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations.

Authors:  Ana Ivanovska; Mengyu Wang; Tarlan Eslami Arshaghi; Georgina Shaw; Joel Alves; Andrew Byrne; Steven Butterworth; Russell Chandler; Laura Cuddy; James Dunne; Shane Guerin; Rob Harry; Aidan McAlindan; Ronan A Mullins; Frank Barry
Journal:  Front Vet Sci       Date:  2022-06-10

7.  Equine bone marrow-derived mesenchymal stem cells: optimization of cell density in primary culture.

Authors:  Morteza Zahedi; Abbas Parham; Hesam Dehghani; Hossein Kazemi Mehrjerdi
Journal:  Stem Cell Investig       Date:  2018-10-09

8.  Equine adipose-derived mesenchymal stem cells: phenotype and growth characteristics, gene expression profile and differentiation potentials.

Authors:  Faezeh Alipour; Abbas Parham; Hossein Kazemi Mehrjerdi; Hesam Dehghani
Journal:  Cell J       Date:  2015-01-13       Impact factor: 2.479

9.  Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.

Authors:  Amandine Breton; Ruchi Sharma; Andrea Catalina Diaz; Alea Gillian Parham; Audrey Graham; Claire Neil; Christopher Bruce Whitelaw; Elspeth Milne; Francesc Xavier Donadeu
Journal:  Stem Cells Dev       Date:  2012-09-28       Impact factor: 3.272

Review 10.  Stem Cells Applications in Regenerative Medicine and Disease Therapeutics.

Authors:  Ranjeet Singh Mahla
Journal:  Int J Cell Biol       Date:  2016-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.